Is Intravenous Iron Treatment in Pediatric Patients Safe and Effective Enough?

Creative Commons License

Karadaş N., Töret E., Karadaş U.

GUNCEL PEDIATRI, cilt.20, sa.2, ss.168-173, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/jcp.2022.94940
  • Dergi Adı: GUNCEL PEDIATRI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, Veterinary Science Database
  • Sayfa Sayıları: ss.168-173
  • Anahtar Kelimeler: Iron deficiency anemia, intravenous treatment, effectivity, safety, DEFICIENCY ANEMIA, FERRIC CARBOXYMALTOSE, CHILDREN, EFFICACY, THERAPY, ADOLESCENTS, PREVENTION, PREVALENCE, DIAGNOSIS, INFANTS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Introduction: Iron deficiency anemia (IDA) is the most common hematological disease among infants and children. Although most of the children with IDA are treated with oral iron preparations, intravenous (IV) iron is an alternative for children with severe IDA who have difficulty in adhering to or absorbing oral iron. In this study, the reasons of IDA in patients treated with IV iron and the effectivity and safety of iron sucrose preparations in pediatric patients were evaluated.